Abstract
This study examined the association between T1198C polymorphism of the angiotensinogen (AGT) gene and the blood pressure response to ACE inhibitors in a Chinese hypertensive cohort. After a 2-week single-blind placebo run-in period, benazepril (10–20 mg/day) or imidapril (5–10 mg/day) was administered for 6 weeks to 509 patients with mild-to-moderate essential hypertension. Polymerase chain reaction combined with restriction enzyme digestion was used to detect the polymorphism, and the patients were classified as having the TT, TC, or CC genotype. The achieved changes in systolic and diastolic blood pressure (SBP and DBP) were analyzed to determine their association with genotypes at the AGT gene locus. In the total 509 patients, the TT genotype was observed in 44 patients (8.7%), the TC genotype in 214 patients (42.0%), and the CC genotype in 251 patients (49.3%). The SBP reductions in patients with the TT genotype, TC genotype, and CC genotype were −15.3±12.7 mmHg, −14.0±12.7 mmHg, and −14.4±12.4 mmHg, respectively (p=0.809). The DBP reductions in patients with the TT genotype, TC genotype, and CC genotype were −8.5±8.1 mmHg, −8.3±7.5 mmHg, and −8.9±6.6 mmHg, respectively (p=0.638). There were no significant differences in the changes in SBP or DBP after treatment among the three genotype groups. In conclusion, these results suggest that the AGT genotype does not predict the blood pressure-lowering response to antihypertensive treatment with ACE inhibitors in Chinese hypertensive patients.
Similar content being viewed by others
Article PDF
References
Matsubara M, Metoki H, Katsuya T, et al: T+31C polymorphism (M235T) of the angiotensinogen gene and home blood pressure in the Japanese general population: the Ohasama Study. Hypertens Res 2003; 26: 37–46.
Jin JJ, Nakura J, Wu Z, et al: Association of angiotensin II type 2 receptor gene variant with hypertension. Hypertens Res 2003; 26: 547–552.
Ono K, Mannami T, Baba S, Yasui N, Ogihara T, Iwai N : Lack of association between angiotensin II type 1 receptor gene polymorphism and hypertension in Japanese. Hypertens Res 2003; 26: 131–134.
Kikuya M, Sugimoto K, Katsuya T, et al: A/C1166 gene polymorphism of the angiotensin II type 1 receptor (AT1) and ambulatory blood pressure: the Ohasama Study. Hypertens Res 2003; 26: 141–145.
Matsubara M, Sato T, Nishimura T, et al: CYP11B2 polymorphisms and home blood pressure in a population-based cohort in Japanese: the Ohasama Study. Hypertens Res 2004; 27: 1–6.
Kurland L, Liljedahl U, Karlsson J, et al: Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Am J Hypertens 2004; 17: 8–13.
Kurland L, Melhus H, Karlsson J, et al: Aldosterone synthase (CYP11B2) −344 C/T is related to antihypertensive response. Am J Hypertens 2002; 15: 387–393.
Sasaki M, Oki T, Luchi A, et al: Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies. J Hypertens 1996; 14: 1403–1408.
Dudley C, Keavney B, Casadei B, Conway J, Bird R, Ratcliffe P : Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of the renin-angiotensin system genes. J Hypertens 1996; 14: 259–262.
Nakano Y, Oshima T, Watanabe M, Matsuura H, Kajiyama G, Kambe M : Angiotensin I-converting enzyme gene polymorphism and acute response to captopril in essential hypertension. Am J Hypertens 1997; 10: 1064–1068.
Ueda S, Meredith PA, Morton JJ, Connell JMC, Elliott L : ACE (I/D) genotype as a predictor of the magnitude and duration of the response an ACE inhibitor drug (enalaprilat) in humans. Criculation 1998; 98: 2148–2153.
Liljedahl U, Karlsson J, Melhus H, et al: A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response. Pharmacogenetics 2003; 13: 7–17.
Miller JA, Thai K, Scholey JW : Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II. Kidney Int 1999; 56: 2173–2180.
Katsuya T, Iwashima Y, Sugimoto K, et al: Effects of antihypertensive drugs and gene variants in the renin-angiotensin system. Hypertens Res 2001; 24: 463–467.
Nakamura Y, Tamaki S, Uchida Y, et al: Angiotensin converting enzyme genotype influences the response to the angiotensin II receptor antagonist losartan in patients with hypertension. Hypertens Res 2004; 27: 137–140.
Yu H, Zhang Y, Lu G : Relationship between the polymorphism of the angiotensin converting enzyme gene and the response to angiotensin converting enzyme inhibition in hypertensive patients. Hypertens Res 2003; 26: 881–886.
Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169–180.
Kunz R, Kreutz R, Beige J, Distler A, Sharma AM : Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 1997; 30: 1331–1337.
Staessen JA, Kuznetsova T, Wang JG, Emelianov D, Vlietinck R, Fagard R : M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens 1999; 17: 9–17.
Katsuya T, Ishikawa K, Sugimoto K, Rakugi H, Ogihara T : Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res 2003; 26: 521–525.
Poch E, Gonzalez D, Giner V, Bragulat E, Coca A, de la Sierra A : Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension 2001; 38: 1204–1209.
Rotimi C, Puras A, Cooper R, et al: Polymorphism of renin-angiotensin genes among Nigerians, Jamaicans, and African Americans. Hypertension 1996; 27: 558–563.
Caufield M, Lavender P, Newell Price J, et al: Linkage of the AGT gene to human EH in African Caribbeans. J Clin Invest 1995; 96: 687–692.
Imidapril and Benazepril Clinical Study Cooperation Unit : Comparative Study of Hypotensive Efficacy and the Cough Occurrence of Imidapril versus Benazepril. Chin J Cardiol 2004; 32: 304–307.
Mondorf UF, Russ A, Wiesemann A, Herrero M, Oremek G, Lenz T : Contribution of ACE gene polymorphism and angiotensinogen gene polymorphism to blood pressure reduction in essential hypertension. Am J Hypertens 1998; 11: 174–183.
Walker WG, Welton PK, Saito H, Rusell RP, Hermann J : Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1979; 1: 287–291.
Hegele RA, Brunt JH, Connelly PW : A polymorphism of the angiotensin gene associated with variation in blood pressure in a genetic isolate. Circulation 1994; 90: 2207–2212.
Sethi AA, Nordestgaard BG, Tybjærg-Hansen A : Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol 2003; 23: 1269–1275.
Hingorani AD, Jia H, Stevens PA, Hopper R, Dickerson JE, Brown MJ : Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens 1995; 13: 1602–1609.
Takahashi N, Hagaman JR, Kim HS, Smithies O : Computer simulations of blood pressure regulation by the renin-angiotensin system. Endocrinology 2003; 144: 2184–2190 ( Minireview).
Juillerat L, Nussberger J, Menard J, et al: Determinants of angiotensin II generation during ACE inhibition. Hypertension 1990; 16: 564–572.
Caulfield M, Lavender P, Farrall M, et al: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994, 330: 1629–1633.
Martin ER, Lai EH, Gilbert JR, et al: SNPing away at complex disease: analysis of singe-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet 2000; 67: 383–394.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yu, H., Lin, S., Liu, G. et al. T1198C Polymorphism of the Angiotensinogen Gene and Antihypertensive Response to Angiotensin-Converting Enzyme Inhibitors. Hypertens Res 28, 981–986 (2005). https://doi.org/10.1291/hypres.28.981
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.28.981
